Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes

Overview of attention for article published in Diabetologia, November 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHOD FOR REGULATING AND CONTROLING GLP-1/GLP-1R AND DRUG

Application WO-2018233604-A1

World Intellectual Property Organisation (WIPO)